These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10468895)

  • 41. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
    Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase.
    Shiraishi A; Sakumi K; Sekiguchi M
    Carcinogenesis; 2000 Oct; 21(10):1879-83. PubMed ID: 11023546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives.
    Okamoto R; Takano H; Okamura T; Park JS; Tanimoto K; Sekikawa T; Yamamoto W; Sparreboom A; Verweij J; Nishiyama M
    Jpn J Cancer Res; 2002 Jan; 93(1):93-102. PubMed ID: 11802813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypersensitivity of human tumor xenografts lacking O6-alkylguanine-DNA alkyltransferase to the anti-tumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitros ourea.
    Fujio C; Chang HR; Tsujimura T; Ishizaki K; Kitamura H; Ikenaga M
    Carcinogenesis; 1989 Feb; 10(2):351-6. PubMed ID: 2912585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement effect of O6-fluorobenzylguanines on chloroethylnitrosourea cytotoxicity in tumor cells.
    Mineura K; Fukuchi M; Kowada M; Hitomi K; Terashima I; Kohda K
    Life Sci; 1996; 58(19):PL303-8. PubMed ID: 8632694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
    Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
    Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide.
    Chinnasamy D; Fairbairn LJ; Neuenfeldt J; Treisman JS; Hanson JP; Margison GP; Chinnasamy N
    Hum Gene Ther; 2004 Aug; 15(8):758-69. PubMed ID: 15319033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents.
    Wang G; Weiss C; Sheng P; Bresnick E
    Biochem Pharmacol; 1996 May; 51(9):1221-8. PubMed ID: 8645346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study on MGMT assay and tumor individual predictable chemotherapy].
    Zhang YP
    Ai Zheng; 2004 Jun; 23(6):724-34. PubMed ID: 15191682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
    Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
    Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
    Tanaka S; Akimoto J; Narita Y; Oka H; Tashiro T
    J Neurosurg; 2014 Oct; 121(4):818-26. PubMed ID: 25105699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
    Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
    Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
    Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
    Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated expression of DNA polymerase beta gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea.
    Gomi A; Shinoda S; Sakai R; Hirai H; Ozawa K; Masuzawa T
    Biochem Biophys Res Commun; 1996 Oct; 227(2):558-63. PubMed ID: 8878552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-methyl-N'-nitro-N-nitrosoguanidine-resistant HeLa S3 cells still have little O6-methylguanine-DNA methyltransferase activity and are hypermutable by alkylating agents.
    Ishida R; Takahashi T
    Carcinogenesis; 1987 Aug; 8(8):1109-13. PubMed ID: 3608093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course.
    Watanabe T; Katayama Y; Komine C; Yoshino A; Ogino A; Ohta T; Fukushima T
    Int J Cancer; 2005 Feb; 113(4):581-7. PubMed ID: 15455376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas.
    Nakasu S; Fukami T; Baba K; Matsuda M
    J Neurooncol; 2004 Dec; 70(3):333-40. PubMed ID: 15662974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells.
    Milsom MD; Jerabek-Willemsen M; Harris CE; Schambach A; Broun E; Bailey J; Jansen M; Schleimer D; Nattamai K; Wilhelm J; Watson A; Geiger H; Margison GP; Moritz T; Baum C; Thomale J; Williams DA
    Cancer Res; 2008 Aug; 68(15):6171-80. PubMed ID: 18676840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear-localizing O6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker.
    Choi U; DeRavin SS; Yamashita K; Whiting-Theobald N; Linton GF; Loktionova NA; Pegg AE; Malech HL
    Exp Hematol; 2004 Aug; 32(8):709-19. PubMed ID: 15308322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors.
    Allay JA; Koç ON; Davis BM; Gerson SL
    Clin Cancer Res; 1996 Aug; 2(8):1353-9. PubMed ID: 9816307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.